Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS.
A controlled trial of mitoxantrone in multiple sclerosis: serial MRI evaluation at one year.
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.
Company restores access to multiple sclerosis drug after pressure from neurologists.
Amiloride: a molecular probe of sodium transport in tissues and cells.
First proof for rituximab in IgG4-related disease
Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility.
Intellectual enrichment lessens the effect of brain atrophy on learning and memory in multiple sclerosis.
Treatment of neuromyelitis optica.
Varicella-Zoster Virus Infections in Patients Treated With Fingolimod: Risk Assessment and Consensus Recommendations for Management.
CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease.
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis.
A promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitis.
Long-Term Cost-Effectiveness Model of Interferon Beta-1b in the Early Treatment of Multiple Sclerosis in the United States.
Drak2 Does Not Regulate TGF-β Signaling in T Cells.
Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma
IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis.
Bruxism and temporal bone hypermobility in patients with multiple sclerosis.
Assessment of Disease Activity in Multiple Sclerosis Phenotypes with Combined Gadolinium- and Superparamagnetic Iron Oxide-enhanced MR Imaging.
PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms.
Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS.
Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis.
Alerting Network Dysfunction in Early Multiple Sclerosis.
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.
Imaging Neurodegeneration and Repair in Multiple Sclerosis

Pages